Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel F Jonkman

Showing results (91-100 of 124) with videos related to

Pageof 13
Sort By:
Scientific Reports|February 21, 2018
Human antibody responses against non-covalently cell wall-bound Staphylococcus aureus proteinsFrancisco Romero Pastrana, Jolanda Neef, Dennis G A M Koedijk, et al.
Science Translational Medicine|November 28, 2014
Induced pluripotent stem cells from human revertant keratinocytes for the treatment of epidermolysis bullosaNoriko Umegaki-Arao, Anna M G Pasmooij, Munenari Itoh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 16, 2014
Recombinant human IgA1 and IgA2 autoantibodies to type VII collagen induce subepidermal blistering ex vivoAndreas Recke, Luisa M Trog, Hendri H Pas, et al.
Archives of Dermatology|May 17, 2006
Randomized controlled trial of adjuvant oral dexamethasone pulse therapy in pemphigus vulgaris: PEMPULS trialLeon F Mentink, Maria W Mackenzie, Gábor G Tóth, et al.
Journal of the American Academy of Dermatology|February 21, 2012
Sensitive and specific assays for routine serological diagnosis of epidermolysis bullosa acquisitaLars Komorowski, Ralf Müller, Artem Vorobyev, et al.
Journal of Autoimmunity|September 18, 2012
Recombinant IL-6 treatment protects mice from organ specific autoimmune disease by IL-6 classical signalling-dependent IL-1ra inductionUnni Krishna S R L Samavedam, Kathrin Kalies, Jürgen Scheller, et al.
Infection and Immunity|November 19, 2014
IgG4 subclass-specific responses to Staphylococcus aureus antigens shed new light on host-pathogen interactionJasper Swierstra, Stephanie Debets, Corné de Vogel, et al.
Journal of Dermatological Science|August 12, 2009
Long-term follow-up of patients with recessive dystrophic epidermolysis bullosa in the Netherlands: expansion of the mutation database and unusual phenotype-genotype correlationsPeter C van den Akker, Anthonie J van Essen, Marian M J Kraak, et al.
Molecular Therapy. Nucleic Acids|November 1, 2019
Natural Exon Skipping Sets the Stage for Exon Skipping as Therapy for Dystrophic Epidermolysis BullosaJeroen Bremer, Elisabeth H van der Heijden, Daryll S Eichhorn, et al.
Experimental Dermatology|May 25, 2012
High genetic diversity of Staphylococcus aureus strains colonizing patients with epidermolysis bullosaMagdalena M van der Kooi-Pol, Yanka K Veenstra-Kyuchukova, José C Duipmans, et al.
Pageof 13

Showing results (91-100 of 124) with videos related to

Sort By:
Pageof 13
Scientific Reports|February 21, 2018
Human antibody responses against non-covalently cell wall-bound Staphylococcus aureus proteinsFrancisco Romero Pastrana, Jolanda Neef, Dennis G A M Koedijk, et al.
Science Translational Medicine|November 28, 2014
Induced pluripotent stem cells from human revertant keratinocytes for the treatment of epidermolysis bullosaNoriko Umegaki-Arao, Anna M G Pasmooij, Munenari Itoh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 16, 2014
Recombinant human IgA1 and IgA2 autoantibodies to type VII collagen induce subepidermal blistering ex vivoAndreas Recke, Luisa M Trog, Hendri H Pas, et al.
Archives of Dermatology|May 17, 2006
Randomized controlled trial of adjuvant oral dexamethasone pulse therapy in pemphigus vulgaris: PEMPULS trialLeon F Mentink, Maria W Mackenzie, Gábor G Tóth, et al.
Journal of the American Academy of Dermatology|February 21, 2012
Sensitive and specific assays for routine serological diagnosis of epidermolysis bullosa acquisitaLars Komorowski, Ralf Müller, Artem Vorobyev, et al.
Journal of Autoimmunity|September 18, 2012
Recombinant IL-6 treatment protects mice from organ specific autoimmune disease by IL-6 classical signalling-dependent IL-1ra inductionUnni Krishna S R L Samavedam, Kathrin Kalies, Jürgen Scheller, et al.
Infection and Immunity|November 19, 2014
IgG4 subclass-specific responses to Staphylococcus aureus antigens shed new light on host-pathogen interactionJasper Swierstra, Stephanie Debets, Corné de Vogel, et al.
Journal of Dermatological Science|August 12, 2009
Long-term follow-up of patients with recessive dystrophic epidermolysis bullosa in the Netherlands: expansion of the mutation database and unusual phenotype-genotype correlationsPeter C van den Akker, Anthonie J van Essen, Marian M J Kraak, et al.
Molecular Therapy. Nucleic Acids|November 1, 2019
Natural Exon Skipping Sets the Stage for Exon Skipping as Therapy for Dystrophic Epidermolysis BullosaJeroen Bremer, Elisabeth H van der Heijden, Daryll S Eichhorn, et al.
Experimental Dermatology|May 25, 2012
High genetic diversity of Staphylococcus aureus strains colonizing patients with epidermolysis bullosaMagdalena M van der Kooi-Pol, Yanka K Veenstra-Kyuchukova, José C Duipmans, et al.
Pageof 13